Rhodiola Rosea for Athletic Performance

The De Bock et al. 2004 trial of Rhodiola rosea in trained cyclists, published in the International Journal of Sport Nutrition and Exercise Metabolism, established the modern protocol for Rhodiola as an acute ergogenic aid: 200 mg of standardized SHR-5 extract taken 60 minutes before exercise, with significant improvement in time-to-exhaustion, reduction in heart rate response to submaximal exercise, and reduction in the rating of perceived exertion (RPE) at matched workload. The mechanism is multifaceted — reduced lactate accumulation suggesting improved lactate-threshold and metabolic efficiency, improved fatty acid mobilization sparing muscle glycogen, reduced exercise-induced oxidative damage, and adrenal catecholamine moderation. The Soviet research program (Spasov, Krasik) originally developed Rhodiola as a fatigue-prophylaxis agent for military Special Forces operating in extreme cold and at high altitude, and the standardized SHR-5 extract was supplied to Soviet Olympic athletes through the 1970s and 1980s as a state-approved ergogenic. This deep-dive walks through the De Bock 2004 protocol in clinical detail, the lactate-threshold improvement evidence, the perceived-exertion reduction mechanism (likely central monoaminergic), the military fatigue-prophylaxis research, and the practical 60-minutes-before-exercise dosing protocol.

Viking, Sherpa, and Soviet Athletic History
The De Bock 2004 Endurance Trial
Lactate Threshold Improvement
Perceived Exertion Reduction
Muscle Glycogen Sparing and Fatty Acid Mobilization
Reduced Exercise-Induced Oxidative Damage
Cardiovascular Efficiency and Heart Rate Response
Military Fatigue Prophylaxis (Spasov)
Acute Pre-Exercise vs Chronic Daily Dosing
The 60-Minutes-Before-Exercise Dosing Protocol
Cautions and Drug Interactions
Key Research Papers
Connections

Viking, Sherpa, and Soviet Athletic History

The athletic-performance use of Rhodiola rosea predates modern sports nutrition by approximately a millennium. The traditional uses cluster around populations facing extreme physical demands under extreme environmental stress — cold, altitude, sustained exertion, and the combination of all three.

The Norse Vikings of the 8th-11th centuries reportedly brewed Rhodiola root as a tea consumed in quantity before long sea voyages and military engagements, and the herb is documented as part of the Viking-era pharmacopoeia in the historical sagas of Iceland and the Orkney Islands. The herb was credited with increasing physical strength, endurance, and the cold tolerance needed to survive the open-boat crossings of the North Atlantic.

The Sherpa and Tibetan populations of the high Himalayas have used Rhodiola for centuries as an altitude-adaptation aid. Tibetan medical texts describe the herb for «mountain sickness,» lung ailments, and the general debility of high-altitude living. The mechanism — improved oxygen utilization, enhanced erythropoiesis, and reduced HPA-axis stress response — aligns with the hypoxia-adaptation requirements of populations living at 3,000-5,000 meters elevation. Modern preclinical work has confirmed that salidroside improves hypoxia tolerance in animal models, providing molecular support for the traditional use.

The Soviet athletic use program is the most extensively documented of the historical applications. Beginning in 1969 with formal Soviet Ministry of Health and Pharmacopoeia Commission authorization, standardized Rhodiola rosea extract was supplied to:

Soviet Olympic athletes for general training support and competition preparation
Soviet Special Forces (Spetsnaz) units operating in extreme cold (Arctic, high altitude, Siberian winter conditions)
Soviet military pilots completing long-duration combat air patrol
Soviet submarine crews during extended underwater deployments
Soviet cosmonauts in the Salyut and later Mir space programs
Polar expedition members

The Soviet ergogenic-aid program operated parallel to the better-known doping programs but with a different rationale — Rhodiola was classified as a legal natural adaptogen rather than a banned performance-enhancing drug, and its use continued openly through the 1970s and 1980s. Much of the Soviet-era performance data was published only in Russian-language journals and remained inaccessible to Western sports science until the 1990s.

Back to Table of Contents

The De Bock 2004 Endurance Trial

De Bock K, Eijnde BO, Ramaekers M, Hespel P (2004) at the Catholic University of Leuven in Belgium published the modern reference trial for acute Rhodiola supplementation in trained athletes, in the International Journal of Sport Nutrition and Exercise Metabolism. The trial design tested the acute (single-dose, pre-exercise) effect of Rhodiola on endurance exercise capacity in a population of recreationally active healthy young adults.

Trial details:

Population: 24 healthy young adults (12 men, 12 women), aged 19-31, all with VO2max in the recreationally-active range
Design: randomized, double-blind, placebo-controlled, crossover — each subject completed two sets of exercise tests, one after Rhodiola and one after placebo, separated by 4-week washout
Dose: 200 mg of standardized SHR-5 extract (3% rosavins / 1% salidroside) taken 60 minutes before exercise, on an empty stomach
Exercise protocol: incremental cycle ergometer test to exhaustion, with measurement of time-to-exhaustion, heart rate response at each workload, blood lactate concentration at each workload, and rating of perceived exertion (RPE)

Results in the Rhodiola condition compared to placebo:

Time to exhaustion: significantly increased (by approximately 3% on average, statistically significant)
Total work output: increased
VO2max: increased (significant for the women in the cohort)
Heart rate: reduced at every submaximal workload — subjects achieved the same external work at lower cardiac stress
Blood lactate: reduced accumulation at matched workloads, consistent with improved metabolic efficiency
Rating of perceived exertion (RPE): reduced at matched workloads — the same exercise felt subjectively easier

The absolute magnitude of the time-to-exhaustion improvement (approximately 3%) is small in athletic terms but meaningful at the margins of competitive performance. More importantly, the reduction in heart rate and RPE at submaximal workloads indicates a real change in exercise physiology rather than a placebo effect on motivation. The herb appears to improve the cost-per-watt of exercise, not just the willingness to suffer.

Back to Table of Contents

Lactate Threshold Improvement

The lactate threshold is the exercise intensity at which blood lactate concentration begins to accumulate above baseline — the point at which anaerobic metabolism begins to substantially contribute to ATP production and metabolic byproducts begin to limit sustainable exercise duration. The lactate threshold is one of the most physiologically meaningful determinants of endurance performance, more predictive than VO2max for the actual question of how long an athlete can sustain a given pace.

The De Bock 2004 trial documented reduced blood lactate accumulation at matched submaximal workloads after Rhodiola supplementation, suggesting that the lactate threshold shifted to a slightly higher workload. The mechanism is likely multifactorial:

Improved mitochondrial function — Rhodiola supports mitochondrial biogenesis and respiratory chain efficiency, allowing more ATP production via aerobic oxidation and less reliance on glycolytic fermentation
Enhanced fatty acid oxidation — fatty acid beta-oxidation produces ATP without lactate as a byproduct, while glucose metabolism produces lactate; shifting substrate utilization toward fats reduces lactate accumulation
Improved lactate clearance — both hepatic and cardiac lactate uptake and oxidation appear to improve with Rhodiola supplementation in animal studies
AMPK activation — AMP-activated protein kinase is the master regulator of cellular energy homeostasis, and Rhodiola compounds activate AMPK in muscle tissue, promoting both glucose uptake and fatty acid oxidation

The clinical implication for endurance athletes is that Rhodiola may modestly improve sustainable race pace at the lactate-threshold-limited intensities that determine performance in events from 10K running to marathon to time-trial cycling to Olympic-distance triathlon. The effect size is modest (single-digit percent) but real and consistent across the trials.

Back to Table of Contents

Perceived Exertion Reduction

The rating of perceived exertion (RPE) is the subjective measure of how hard an exercise effort feels to the athlete, typically measured on the Borg 6-20 scale or the modified Borg 0-10 scale. RPE is determined by both peripheral signals (lactate accumulation, muscle damage, glycogen depletion, body temperature) and central neurological factors (motivation, central fatigue, monoamine neurotransmitter tone, perceived effort versus available capacity).

The consistent finding across endurance-exercise trials is that Rhodiola supplementation reduces RPE at matched external workloads — the same effort feels subjectively easier. Two interacting mechanisms likely contribute:

Peripheral mechanism: reduced lactate accumulation, reduced heart rate response, and reduced exercise-induced oxidative damage all produce less peripheral «distress signaling» from the working muscles to the brain. Less peripheral signal means lower subjective effort.
Central mechanism: the monoamine-availability effect of Rhodiola (increased serotonin, dopamine, and norepinephrine availability through MAO and COMT inhibition) plays into the central-governor model of exercise. Higher central monoamine tone is associated with greater pain tolerance, greater effort tolerance, and lower subjective effort at matched workload. The same mechanism that produces cognitive-performance preservation under stress also produces effort-tolerance during exhausting exercise.

The central component is the more interesting from a sports-science standpoint because it suggests that Rhodiola is not merely a peripheral metabolic enhancer like creatine or beta-alanine, but works at the level of the central nervous system's exercise governance. This positions Rhodiola somewhere between conventional supplements that affect muscle metabolism and pharmacological agents (caffeine, modafinil) that affect central drive — with the unique advantage of producing benefit without the «crash» associated with caffeine and without the side-effect profile of pharmaceutical stimulants.

Back to Table of Contents

Muscle Glycogen Sparing and Fatty Acid Mobilization

Endurance exercise depletes muscle glycogen stores at a rate proportional to exercise intensity. Bonking — the catastrophic depletion of carbohydrate substrate during prolonged exercise — is one of the most consistent limiters of marathon, long-distance cycling, and triathlon performance. Any intervention that spares muscle glycogen by shifting substrate utilization toward fatty acid oxidation extends the duration of sustainable exercise before bonking.

Rhodiola supplementation has been shown in animal models and in some human studies to:

Enhance fatty acid mobilization from adipose tissue stores
Promote fatty acid transport into the mitochondria via increased carnitine palmitoyltransferase (CPT) activity
Increase fatty acid oxidation rates in working muscle
Spare muscle and liver glycogen at submaximal exercise intensities
Enhance post-exercise glycogen resynthesis

The metabolic shift is similar in direction to the adaptations seen with chronic endurance training itself or with deliberate carbohydrate-restriction protocols, but appears more rapidly with acute Rhodiola dosing. The practical implication is that Rhodiola may particularly benefit ultra-endurance athletes (marathon, ultramarathon, ironman triathlon, long bike races) who are limited primarily by glycogen depletion rather than by sprint capacity or maximal power output.

The post-exercise glycogen resynthesis enhancement is interesting because it suggests Rhodiola may also have value in recovery between training sessions, not only as a pre-exercise ergogenic. Athletes in multi-day stage races or in heavy training blocks might benefit from chronic Rhodiola dosing for the recovery effect in addition to acute pre-event dosing for the performance effect.

Back to Table of Contents

Reduced Exercise-Induced Oxidative Damage

Strenuous exercise — particularly novel exercise or training at the edge of capacity — produces substantial oxidative damage through the generation of reactive oxygen species (ROS) during mitochondrial respiration. While moderate ROS production is part of the normal training stimulus that drives adaptation, excessive ROS production from acute extreme exertion contributes to muscle damage, prolonged soreness, and impaired recovery.

Studies of Rhodiola in exercising humans and animals have documented:

Reduced post-exercise creatine kinase elevation (marker of muscle membrane damage)
Reduced post-exercise lactate dehydrogenase elevation (marker of muscle cell damage)
Reduced post-exercise malondialdehyde (a marker of lipid peroxidation, indicating reduced oxidative damage)
Increased post-exercise total antioxidant capacity
Increased post-exercise superoxide dismutase and glutathione peroxidase activity (endogenous antioxidant enzyme systems)
Reduced post-exercise delayed-onset muscle soreness (DOMS) ratings

The mechanism centers on salidroside's activation of the Nrf2/HO-1 antioxidant defense pathway. Nrf2 (nuclear factor erythroid 2-related factor 2) is a master transcription factor that controls the expression of dozens of antioxidant enzymes including superoxide dismutase, catalase, glutathione peroxidase, and the glutathione-synthesis machinery. By upregulating the entire endogenous antioxidant response, Rhodiola provides broader protection than supplementing any single exogenous antioxidant vitamin (like high-dose vitamin C or vitamin E, which have actually been shown to blunt training adaptation in some studies).

The practical implication for athletes is that Rhodiola may particularly benefit recovery in heavy training blocks, eccentric-loading workouts (downhill running, heavy lifting), and in events with significant muscle damage (marathon, ultra-endurance, contact sports). The dose-timing question for recovery is different from the dose-timing question for acute performance — for recovery, daily chronic dosing matters more than acute pre-exercise dosing.

Back to Table of Contents

Cardiovascular Efficiency and Heart Rate Response

The De Bock 2004 finding of reduced heart rate response to submaximal exercise after Rhodiola supplementation has been replicated in subsequent trials. The pattern is consistent: at any matched external workload, heart rate after Rhodiola is 5-10 beats per minute lower than after placebo. The athlete is doing the same work at lower cardiac stress.

The mechanism likely involves multiple components:

Reduced sympathetic outflow — Rhodiola moderates catecholamine release from the adrenal medulla during exercise, reducing the beta-adrenergic stimulation of the heart
Reduced myocardial catecholamine concentration — the heart tissue itself shows lower local catecholamine concentration after Rhodiola, with reduced cyclic AMP elevation
Improved cardiac contractile efficiency — preclinical evidence suggests improved myocardial oxygen utilization, allowing the same stroke volume at lower oxygen demand
Improved peripheral oxygen extraction — better oxygen utilization at the muscle level means the cardiovascular system needs to deliver less oxygen for the same external work

For athletes who train by heart rate zones — the standard approach in endurance sports — this matters in a specific practical way. The same heart rate zones correspond to different absolute workloads after Rhodiola supplementation. Athletes training at «Zone 2» (typically 70-80% of max HR) will actually be doing higher absolute power output at the same heart rate after Rhodiola, which is the training adaptation we want. Conversely, athletes targeting specific external workloads will see slightly lower heart rates at those workloads, which can be misleading when comparing training load before and after starting Rhodiola.

The cardioprotective effect also has implications for older athletes and those with cardiovascular risk factors. The reduced cardiac stress at matched workloads may make heavy exercise safer for individuals with subclinical coronary disease or cardiac arrhythmia susceptibility — though anyone with established cardiovascular disease should consult their cardiologist before starting Rhodiola, particularly if on beta-blockers, ACE inhibitors, or other cardiac medications.

Back to Table of Contents

Military Fatigue Prophylaxis (Spasov)

The Spasov military cadet trial discussed in the Cognitive Performance deep-dive also has direct implications for military fatigue prophylaxis in extended-operations contexts. The trial showed that a single dose of Rhodiola in 161 military cadets aged 19-21 produced significant improvements in:

Capacity for mental and physical work under fatigue
Associative thinking under sleep deprivation
Short-term memory under stress
Calculation speed under time pressure
Reaction time and audiovisual processing

The military fatigue-prophylaxis use case combines both the physical-performance dimension (sustained patrols, equipment-laden marching, combat operations in extreme environments) and the cognitive-performance dimension (situational awareness, communication, target identification, decision-making under stress). Rhodiola is unique among ergogenic aids in addressing both simultaneously, which is why the Soviet military programs prioritized it over single-target agents like amphetamine stimulants or pure-physiological substrate supplements.

Modern military medicine continues to study Rhodiola and related adaptogens for fatigue prophylaxis in special operations, with particular interest in:

Cold-weather operations (Arctic, mountain warfare) — where the traditional altitude-and-cold adaptogen background of Rhodiola is directly relevant
Submarine operations — sustained sleep restriction and circadian disruption
Aviator fatigue management — long-duration combat air patrol and night operations
Recovery from extreme physical training programs — selection courses, ranger school, dive training

The integrative-medicine version of military fatigue prophylaxis applies to civilian populations facing similar demands: emergency department physicians on overnight call, ICU nurses on twelve-hour rotating shifts, long-distance truck drivers, expedition climbers, and ultra-endurance athletes. The mechanism is the same and the dosing protocol is the same.

Back to Table of Contents

Acute Pre-Exercise vs Chronic Daily Dosing

A particularly important distinction in Rhodiola sports use is between acute pre-exercise dosing (single dose 60 minutes before a specific workout or event) and chronic daily dosing (200-400 mg/day taken every day for weeks or months). The two protocols target different physiological objectives and have different supporting evidence:

Acute pre-exercise dosing:

Target: maximize performance for a specific event or workout
Mechanism: rapid monoaminergic effect on perceived exertion, acute catecholamine moderation reducing heart rate response, acute fatty acid mobilization
Evidence: De Bock 2004 directly supports this protocol
Protocol: 200 mg standardized extract, 60 minutes before exercise, on empty stomach
Best for: time trials, races, time-limited testing, single high-intensity training sessions, competitions

Chronic daily dosing:

Target: adaptive support during training blocks, recovery enhancement, sustained stress tolerance
Mechanism: HPA-axis modulation, sustained antioxidant defense upregulation via Nrf2/HO-1, sustained mitochondrial function support, training adaptation enhancement
Evidence: mixed; the chronic-dosing trials for endurance performance per se are smaller and less consistent than the acute trials, but the chronic protocol has clear support for the broader stress and recovery dimensions
Protocol: 200-400 mg/day in divided morning doses, sustained over training cycles of 4-12 weeks
Best for: heavy training blocks, multi-day stage races, military selection courses, ultra-endurance training, recovery from injury or illness

The two protocols are not mutually exclusive and can be combined. A serious endurance athlete in a heavy training block might take 200 mg in the morning every day for sustained support, and add an additional 200 mg 60 minutes before key workouts or races for the acute performance effect. The total daily dose in that combined protocol (400 mg) stays well within the safe range. The pattern of effect is sustained adaptive support plus event-specific acute enhancement.

Back to Table of Contents

The 60-Minutes-Before-Exercise Dosing Protocol

The 60-minute pre-exercise timing of the De Bock 2004 protocol is based on the pharmacokinetics of salidroside and rosavin in humans. Plasma concentration of salidroside peaks approximately 60-90 minutes after oral administration of a standardized extract on an empty stomach, with elimination half-life of approximately 5-6 hours. The 60-minute pre-exercise timing positions the peak plasma concentration during the exercise itself, when the monoaminergic and metabolic effects are most needed.

Detailed protocol:

Dose: 200 mg standardized extract (3% rosavins / 1% salidroside)
Timing: 60 minutes before the start of exercise
With or without food: empty stomach for maximum absorption (food, particularly fatty meals, reduces salidroside bioavailability by approximately 25%)
Fluid: full glass of water
Stimulant stacking: avoid combining with high-dose caffeine, pre-workout formulas containing yohimbine or DMHA, or prescription stimulants — the combined activation can produce arrhythmia susceptibility and acute hypertension during exercise
First-time use: do not test Rhodiola for the first time on race day — trial it in training to assess individual tolerability and to calibrate dose

For events lasting more than 2 hours, some athletes split the dose: 200 mg taken 60 minutes pre-exercise plus an additional 200 mg taken at the 90-minute mark of the exercise itself (which would peak at approximately the 150-minute mark, near the late-event fatigue window). This split-dose protocol has not been formally tested in trials but is used empirically by some endurance athletes; the total dose of 400 mg in a single training session stays within the safe range.

For high-altitude expeditions (mountaineering, ski touring, trekking at >3,000m elevation), chronic daily dosing in the 200-400 mg/day range starting 2-4 weeks before the trip is more appropriate than acute pre-event dosing — the altitude-adaptation mechanism is gradual rather than acute, and the goal is to support the body's natural acclimatization process rather than to push acute performance.

Back to Table of Contents

Cautions and Drug Interactions

Sport doping status — Rhodiola rosea is NOT on the World Anti-Doping Agency (WADA) prohibited list and is permitted in competitive sport. However, athletes subject to drug testing should always verify with their specific governing body and should source Rhodiola from manufacturers with third-party doping-free certification, as adulteration with banned substances has been documented in the broader supplement industry.
Pre-workout stimulant stacking — do not combine Rhodiola with high-dose caffeine, yohimbine, DMHA, synephrine, or pre-workout formulas containing multiple stimulants. The combined activation can produce hypertension, tachyarrhythmia, and rarely serious cardiac events during high-intensity exercise.
Beta-blockers — athletes on beta-blockers for hypertension, anxiety, or cardiac arrhythmia should consult their cardiologist before adding Rhodiola; the catecholamine-moderating effect of Rhodiola may be additive with beta-blockade and produce excessive bradycardia or hypotension during exercise.
Anticoagulants — athletes on warfarin or DOACs (apixaban, rivaroxaban) should monitor for any increased bleeding tendency when starting Rhodiola; INR check is appropriate for warfarin-stabilized patients.
Heart rate-based training — recalibrate heart rate zones after starting Rhodiola; the same external workload will produce lower heart rate, which can be misleading when comparing training load week-over-week.
Hot-environment exercise — Rhodiola does not impair thermoregulation, but the catecholamine moderation may reduce the early-warning subjective effort signal that protects athletes from heat exhaustion; standard hydration and heat-acclimatization protocols remain essential.
Cold-environment exercise — Rhodiola appears to enhance cold tolerance, consistent with its Arctic-adaptation traditional use, but should not substitute for appropriate cold-weather gear and protocol.
Altitude — Rhodiola is helpful for altitude adaptation when dosed chronically before ascent, but is not a substitute for proper acclimatization staging or for descent in symptoms of acute mountain sickness.
Concurrent SSRI/SNRI/MAOI therapy — the same hard rule that applies in the depression context applies in the athletic context: do not combine without specialist supervision due to additive serotonergic risk.

For the broader athletic-supplement context, see our Ginseng page (a related adaptogen with endurance evidence), Schisandra page (often used in combination Soviet/Russian protocols with Rhodiola), and the Fatigue page for the broader fatigue-management context.

Back to Table of Contents

Key Research Papers

De Bock K, Eijnde BO, Ramaekers M, Hespel P (2004). Acute Rhodiola rosea intake can improve endurance exercise capacity. International Journal of Sport Nutrition and Exercise Metabolism, 14(3), 298-307. — PubMed
Lu Y, Deng B, Xu L, Liu H, Song Y, Lin F (2022). Effects of Rhodiola rosea supplementation on exercise and sport: a systematic review. Frontiers in Nutrition, 9, 856287. — PubMed
Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV (2000). A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine, 7(2), 85-89. — PubMed
Noreen EE, Buckley JG, Lewis SL, Brandauer J, Stuempfle KJ (2013). The effects of an acute dose of Rhodiola rosea on endurance exercise performance. Journal of Strength and Conditioning Research, 27(3), 839-847. — PubMed
Parisi A, Tranchita E, Duranti G, Ciminelli E, Quaranta F, Ceci R, Cerulli C, Borrione P, Sabatini S (2010). Effects of chronic Rhodiola rosea supplementation on sport performance and antioxidant capacity in trained males: preliminary results. Journal of Sports Medicine and Physical Fitness, 50(1), 57-63. — PubMed
Skarpanska-Stejnborn A, Pilaczynska-Szczesniak L, Basta P, Deskur-Smielecka E (2009). The influence of supplementation with Rhodiola rosea L. extract on selected redox parameters in professional rowers. International Journal of Sport Nutrition and Exercise Metabolism, 19(2), 186-199. — PubMed
Duncan MJ, Clarke ND (2014). The effect of acute Rhodiola rosea ingestion on exercise heart rate, substrate utilisation, mood state, and perceptions of exertion, arousal, and pleasure/displeasure in active men. Journal of Sports Medicine, 2014, 563043. — PubMed
Jowko E, Sadowski J, Dlugolecka B, Gierczuk D, Opaszowski B, Cieslinski I (2018). Effects of Rhodiola rosea supplementation on mental performance, physical capacity, and oxidative stress biomarkers in healthy men. Journal of Sport and Health Science, 7(4), 473-480. — PubMed
Williams TD, Langley HN, Roberson CC, Rogers RR, Ballmann CG (2021). Effects of short-term Rhodiola rosea (golden root extract) supplementation on anaerobic exercise performance. Journal of Functional Morphology and Kinesiology, 6(1), 18. — PubMed
Ballmann CG, Maze SB, Wells AC, Marshall MR, Rogers RR (2019). Effects of short-term Rhodiola rosea supplementation on aerobic and anaerobic exercise performance in untrained females. European Journal of Sport Science, 19(7), 994-1001. — PubMed
Walpurgis K, Thomas A, Geyer H, Mareck U, Thevis M (2020). Dietary supplement and food contaminations and their implications for doping controls. Foods, 9(8), 1012. (Doping-control context) — PubMed
Panossian A, Wagner H (2005). Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration. Phytotherapy Research, 19(10), 819-838. — PubMed

PubMed Topic Searches

Back to Table of Contents

Connections

Back to Table of Contents